Results 51 to 60 of about 134,137 (295)

Acute myocarditis presenting as a reverse Tako-Tsubo syndrome in a patient with SARS-CoV-2 respiratory infection

European Heart Journal, 2020
Simone Sala , Giovanni Peretto *, Mario Gramegna , Anna Palmisano , Andrea Villatore , Davide Vignale , Francesco De Cobelli, Moreno Tresoldi , Alberto Maria Cappelletti, Cristina Basso, Cosmo Godino, and Antonio Esposito 2,4† Department of Cardiac ...
S. Sala, G. Peretto, M. Gramegna, A. Palmisano, A. Villatore, D. Vignale, F. de Cobelli, M. Tresoldi, A. Cappelletti, C. Basso, C. Godino, A. Esposito   +11 more
semanticscholar   +1 more source

Incidence, risk factors, natural history, and hypothesised mechanisms of myocarditis and pericarditis following covid-19 vaccination: living evidence syntheses and review

British medical journal, 2022
Objectives To synthesise evidence on incidence rates and risk factors for myocarditis and pericarditis after use of mRNA vaccination against covid-19, clinical presentation, short term and longer term outcomes of cases, and proposed mechanisms.
J. Pillay, L. Gaudet, A. Wingert, L. Bialy, A. Mackie, D. Paterson, L. Hartling   +6 more
semanticscholar   +1 more source

Reviewing the current diagnostic and treatment approaches for myocarditis – analysis of literature

Quality in Sport
Introduction: Myocarditis is an inflammatory disease of the heart muscle, presenting with symptoms ranging from mild discomfort to severe cardiac dysfunction.
Damian Zys, Maciej Wojszczyk, Julia Ryniecka, Witold Czyż, Julia Kacperczyk, Marta Chuncia-Ileczko, Michalina Wójcikiewicz, Filip Arczewski, Karol Dziedzic, Julia Kulbacka   +9 more
doaj   +1 more source

Influenza vaccination and myocarditis among patients receiving immune checkpoint inhibitors

Journal for ImmunoTherapy of Cancer, 2019
Background Influenza vaccination (FV) is recommended for patients with cancer. Recent data suggested that the administration of the FV was associated with an increase in immune-related adverse events (irAEs) among patients on immune checkpoint inhibitors
Anju Nohria, Stephane Ederhy, Franck Thuny, Michael Mahmoudi, Alexander R. Lyon, Ryan J. Sullivan, Javid J. Moslehi, Justine V. Cohen, Magid Awadalla, Doll Lauren Alexandra Golden, Syed S. Mahmood, Raza M. Alvi, Nathaniel D. Mercaldo, Malek Z. O. Hassan, Dahlia Banerji, Adam Rokicki, Connor Mulligan, Sean P. T. Murphy, Maeve Jones-O’Connor, Lucie M. Heinzerling, Merna Armanious, Rongras Damrongwatanasuk, Carol L. Chen, Dipti Gupta, Michael C. Kirchberger, Sachin P. Shah, Sarju Ganatra, Paaladinesh Thavendiranathan, Muhammad A. Rizvi, Gagan Sahni, Carlo G. Tocchetti, Valentina Mercurio, Donald P. Lawrence, John D. Groarke, Michael G. Fradley, Kerry L. Reynolds, Tomas G. Neilan   +36 more
doaj   +1 more source

First case of COVID-19 complicated with fulminant myocarditis: a case report and insights

Infection, 2020
Background Coronavirus disease 2019 (COVID-19) has been demonstrated to be the cause of pneumonia. Nevertheless, it has not been reported as the cause of acute myocarditis or fulminant myocarditis.
J. Zeng, Yingxia Liu, Jing Yuan, Fu-xiang Wang, Weibo Wu, Jin-xiu Li, Lifei Wang, Hong-yu Gao, Yao Wang, Changfeng Dong, Yi-Jun Li, Xiaohong Xie, C. Feng, Lei Liu   +13 more
semanticscholar   +1 more source

Systematic analysis of drug-associated myocarditis reported in the World Health Organization pharmacovigilance database

Nature Communications, 2022
While multiple pharmacological drugs have been associated with myocarditis, temporal trends and overall mortality have not been reported. Here we report the spectrum and main features of 5108 reports of drug-induced myocarditis, in a worldwide ...
L. Nguyen, L. Cooper, M. Kerneis, C. Funck-Brentano, J. Silvain, N. Brechot, G. Hékimian, E. Ammirati, Badr Ben M’Barek, alban redheuil, E. Gandjbakhch, K. Bihan, B. Lebrun-Vignes, S. Ederhy, C. Dolladille, J. Moslehi, J. Salem   +16 more
semanticscholar   +1 more source

Association of COPD with adverse outcomes in heart failure patients with preserved ejection fraction

ESC Heart Failure, Volume 12, Issue 2, Page 799-808, April 2025.
Abstract We performed a systematic review and meta‐analysis to detect the impact of chronic obstructive pulmonary disease (COPD) on the prognosis of heart failure patients with preserved ejection fraction (HFpEF). We systematically screened eligible literature from three electronic databases, PubMed, EMBASE and Cochrane Library, up to April 2023.
Shuo Xu, Zhenbang Gu, Wengen Zhu, Shenghui Feng   +3 more
wiley   +1 more source

Cytomegalovirus myocarditis in a patient with systemic lupus erythematosus (SLE) successfully treated with ganciclovir

IDCases, 2018
Myocarditis is an inflammatory disease of the myocardium. Viruses, such as enterovirus, adenovirus, parvovirus B19, HHV6 or cytomegalovirus (CMV) and autoimmune diseases are recognized causes of myocarditis.
Lavinia Maria Saraca, Ludovico Lazzari, Cinzia di Giuli, Alessandro Lavagna, Paola Mezzetti, Daniela Bovelli, Enrico Boschetti, Daniela Francisci   +7 more
doaj   +1 more source

COVID-19 Vaccines and Myocarditis: An Overview of Current Evidence

Biomedicines, 2023
COVID-19 vaccines have been widely used to reduce the incidence and disease severity of COVID-19. Questions have lately been raised about the possibility of an association between COVID-19 vaccines and myocarditis, an inflammatory condition affecting the
Altijana Hromić-Jahjefendić, Abas Sezer, Alaa A. A. Aljabali, Ángel Serrano-Aroca, Murtaza M. Tambuwala, Vladimir N. Uversky, Elrashdy M. Redwan, Debmalya Barh, Kenneth Lundstrom   +8 more
doaj   +1 more source

Recognition and Initial Management of Fulminant Myocarditis

Circulation, 2020
Fulminant myocarditis (FM) is an uncommon syndrome characterized by sudden and severe diffuse cardiac inflammation often leading to death resulting from cardiogenic shock, ventricular arrhythmias, or multiorgan system failure. Historically, FM was almost
R. Kociol, L. Cooper, J. Fang, J. Moslehi, P. Pang, Marwa Sabe, R. Shah, D. Sims, G. Thiene, O. Vardeny   +9 more
semanticscholar   +1 more source